Randomized Trialhigh evidence
Targeted Assessment in High-Risk Patients With Diabetes to Identify Undiagnosed Heart Failure (TARTAN-HF).
Journal of the American College of Cardiology·August 11, 2026·PMID 42615958
Why it mattersHeart failure is a common but often unrecognized complication of diabetes, and early detection enables initiation of disease-modifying therapies. This trial demonstrates that a simple NT-proBNP screening strategy can identify a substantial burden of undiagnosed HF, particularly HFpEF, in high-risk diabetic patients, potentially improving outcomes through earlier treatment.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled